About 1,565,319 results (5,451 milliseconds)

Miscarriage Research - Progesterone and Miscarriage

https://sites.google.com/site/miscarriageresearch/hormones-and-miscarriage/progesterone-research/progesterone-and-miscarriage
Progesterone lower than 12 ng/ml associated with increased miscarriage risk. In women between gestation weeks 4 and 12 in whom no apparent signs of a threatened ...

Miscarriage Research - Miscarriage Statistics

https://sites.google.com/site/miscarriageresearch/miscarriage-general
After two miscarriages, one still has a 91.2% chance of successful pregnancy; drops to 20% after 7 · Miscarriage risk increases with previous losses, smoking, ...

Miscarriage Research - How to Increase Fertility

https://sites.google.com/site/miscarriageresearch/how-to-boost-fertility
Increase estrogen levels (doubles pregnancy rate in IVF) ... CONCLUSION: Administration of supranormal levels of progesterone during early pregnancy caused a ...

US7605122B2 - Human chorionic gonadotropin (hCG) formulations ...

https://patents.google.com/patent/US7605122B2/en
The combination of a VLCD and oral hCG formulation could trigger ... Average weight loss per week in the Low dose group was as follows: Week 1 ...

US20150094227A1 - Pregnancy test device and method - Google ...

https://patents.google.com/patent/US20150094227A1/en
Thus, in a pregnant woman one would expect to observe elevated levels of hCG and low levels of FSH. Accordingly, measurement of FSH can be used to help ...

WO2013102921A2 - Hcg - newer treatment modality for type 2 ...

https://patents.google.com/patent/WO2013102921A2/en
Jul 11, 2013 ... The present invention further disclose a pharmaceutical combination of hCG with one or more anti diabetic agents thereof for treating Type 2 ...

US8680086B2 - Methods for chronic pain management and ...

https://patents.google.com/patent/US8680086B2/en
... a single agent that would modulate this multi-faceted pathophisiology to obtain the desired effect. On a broader level, the current inventors view that, HCG ...

Optional Tests: Nuchal Transluency (NT ... - Cyndi Ayoub, WHNP-BC

https://sites.google.com/site/cyndiayoub/Home/obstetrics/nuchal-transluency-nt-testing
Mar 16, 2011 ... ... levels of beta-hCG and PAPP-A. Beta-hCG and PAPP-A (pregnancy ... Remember that an increase risk result on NT testing does not confirm the fetus ...

WO2021133430A1 - Progesterone formulation to trigger ovulation ...

https://patents.google.com/patent/WO2021133430A1/en
... increase the likelihood of a successful pregnancy. These techniques ... Patient's hCG 2 weeks post trigger was 178 and increased to 1459 four days later.

US10786518B2 - Compositions and methods of treating HIV ...

https://patents.google.com/patent/US10786518B2/en
6 : Median fasting lipid levels at baseline and week 48 (A) total ... A woman, except when postmenopausal, must have a negative wine pregnancy test at screening.

WO2012101268A1 - In vitro method to determine the risk of a ...

https://patents.google.com/patent/WO2012101268A1/en
Aug 2, 2012 ... Figure 6 is a box and whisker plot of PNP multiple of the median (MoM) values in women with normal and Down Syndrome pregnancy. ... low, 2=normal, ...

LAPAROSCOPIC SALPINGECTOMY FOR ... - Google Answers

http://answers.google.com/answers/threadview/id/782063.html
Nov 12, 2006 ... ... levels were checked regularly (about 2 x's a week). ... If methotrexate is successful, hCG levels should decline to zero over the next two to six ...

US9492566B2 - Antibody-drug conjugates and uses thereof ...

https://patents.google.com/patent/US9492566B2/en
Alternatively, an ADC may be administered as one dosage every 2 or 3 weeks, repeated for a total of at least 3 dosages. ... 2-PDox resulted in similarly low ...

US7737128B2 - Pyrimidines, such as uridine, in treatments for ...

https://patents.google.com/patent/US7737128B2/en
1 , bipolar patients exhibited a slight decrease in average MADRS scores during the first three weeks of treatment. ... 2 reported increased flatulence, and 1 ...

CA2819080A1 - Agtr1 as a marker for bevacizumab combination ...

https://www.google.com/patents/CA2819080A1?cl=en
... levels in a biological patient sample. In one embodiment, the expression ... week, every 2 weeks or every 3 weeks. Further examples of dosages are 5 mg ...

WO2016106180A1 - Anti-csf1r antibodies for treating pvns - Google ...

https://patents.google.com/patent/WO2016106180A1/en
... weeks (± 2 weeks) (see section 7.2.10) until ... Dose escalation will continue until 2 of 3-6 patients treated at a dose level experience a DLT.

WO2020071912A1 - Extended release formulations of human ...

https://patents.google.com/patent/WO2020071912A1/en
... hCG levels with a corresponding rise in serum testosterone levels (FIG. 23). Serum levels reached a steady state by day 3. However, both serum hCG and serum ...

US6288033B1 - Treatment of hepatitis B infection with thymosin ...

https://patents.google.com/patent/US6288033B1/en
6 HBV DNA>4,000 MEq/ml on 2 determinations>4 weeks apart. If the second HBV DNA determination is ≦4,000 MEq/ml, a 3rd determination must be done 4 weeks after ...

US7818691B2 - Zeroclick - Google Patents

https://patents.google.com/patent/US7818691B2/en
42 a-d show a variation of the HCG in the form of a hierarchical tree view. FIG. 43 shows how the HCG could be operated by the keyboard in addition to pointer ...

WO2017205101A1 - Methods for treatment of refractory generalized ...

https://patents.google.com/patent/WO2017205101A1/en
... must have been on a stable dose for >2 weeks prior to screening. ... A clinically meaningful improvement in a patient's MG-QOL 15 would be an increase ...